News Details

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver Congress

About Arrowhead Pharmaceuticals, Inc.

Price Chart